SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending following news of its progress supporting NVIDIA's next-generation AI factory computing platforms, specifically focused on 800V power architecture. The community is discussing the potential for a short squeeze and the company's role in AI infrastructure, with some drawing comparisons to other high-flying stocks. Bullish sentiment is fueled by the potential for increased efficiency and reduced energy consumption in AI data centers.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp ($LAES) is trending following news of a strategic collaboration with Wecan Group to develop a post-quantum KYC solution, positioning the company as a key player in cybersecurity. The community is buzzing about the potential for a gamma squeeze due to options expiring soon, with some anticipating a significant rise towards double digits. Small cap investors are particularly excited about the upside potential of this stock in the quantum technology and AI revolution.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors discuss Shah Capital's push for the company's sale to a larger pharmaceutical entity to unlock shareholder value. The community is debating the potential buyout price, partnership opportunities, and the company's future prospects under new ownership. Some are frustrated with current management, while others remain optimistic about Novavax's fundamentals and technology.

Greenwave Technology Solutions, Inc. is an emerging growth company, which engages in recycling ferrous metal. It also recycles nonferrous metals including aluminum, copper, stainless steel, nickel, brass, titanium, lead, alloys, and mixed metal products. The company was founded on April 26, 2013 and is headquartered in Chesapeake, VA.

Greenwave Technology Solutions Inc

GWAV is trending due to a planned reverse stock split, which is sparking discussions about potential short squeezes and future price movements. While some traders are optimistic about quick gains, others express concern over the company's history of reverse splits and potential dilution. The community is actively debating the stock's short-term potential versus long-term risks.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst is trending as investors discuss the company's acquisition of Astria Therapeutics for $700M, a move aimed at bolstering their HAE portfolio with a late-stage, long-acting plasma kallikrein inhibitor; navenibart. Community chatter revolves around the deal's financial implications, potential dilution, and the strategic shift from in-house development to acquisitions, with some expressing concerns over increased debt and the timeline for potential returns while others are optimistic about the company's strengthened position in the HAE market.

Nova Minerals Ltd. engages in the exploration and development of mineral properties. Its projects include Estelle Gold, RPM, Korbel, Train, Stoney and Studies projects. The company was founded in January 1987 and is headquartered in Melbourne, Australia.

Nova Minerals Limited - ADR

Nova Minerals is trending due to positive updates on their Alaskan gold and antimony project, including high-grade gold assay results and news of extinguished debt, sparking investor interest. The community is discussing the company's potential to benefit from increased antimony prices and its undervalued status compared to peers. There is also speculation about the company receiving government grants to develop a domestic antimony supply chain.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing volatility amid escalating U.S.-China trade tensions, with the community closely watching support levels and potential for a bounce. Community members are actively trading both bullish and bearish scenarios, awaiting commentary from Fed Chair Powell later in the day. Some traders believe overall market conditions make interpreting the impact of trade tensions difficult to predict.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase & Co. is trending due to a mix of factors, including recent earnings that beat expectations, though the stock price has reacted negatively, sparking community discussion about dip-buying opportunities and the potential for a broader market correction. Investors are also weighing the impact of JPMorgan's increased dividend and a substantial investment initiative focused on national security and technology. Concerns about asset valuations and future market volatility, as highlighted by CEO Jamie Dimon, add another layer to the ongoing conversation surrounding $JPM.

StableX Technologies, Inc. engages in the design, development, manufacture, and sale of compact electric fleet solutions for use within urban and short-haul markets. It offers the AYRO 311 and Club Car 411 models. The company was founded on May 19, 2016 and is headquartered in New York, NY.

StableX Technologies Inc.

StableX Technologies, Inc. 

SBLX is trending due to social media attention highlighting its low float and potential for a rapid price increase, similar to other recent low-float runners. Community members are discussing the company's cash position and a recently announced stablecoin strategy, while some caution against potential pump-and-dump schemes. The stock's past performance as AYRO, Inc. is also being heavily debated, with some users expressing skepticism and others highlighting potential catalysts.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics ($CADL) is trending due to positive community sentiment surrounding a recent $130M term loan, viewed as a strategic move to independently advance their lead lung cancer treatment and bypass potential dilution. Investors are actively discussing the implications for future partnerships or a buyout, with many believing the company is positioned for long-term growth and value creation. Community members are also focused on upcoming data releases, particularly related to CAN-3110, and speculating on potential partnership announcements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
